| Pharmaceutical Information |
| Drug Name |
Polymyxin b |
| Drug ID |
BADD_D01794 |
| Description |
Polymyxin B was discovered in the 1940s[A176429]. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes[A176426]. Polymyxin B is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic[A176426,FDA Label]. All gram-positive bacteria, fungi, and the gram-negative cocci, are resistant[A176426]. It is appropriate for treatment of infections of the urinary tract, meninges, and blood stream, caused by susceptible strains of _Pseudomonas aeruginosa_[FDA Label]. Polymyxin B has a narrow therapeutic index and so its use is limited and unlikely to be used first line[A176429]. |
| Indications and Usage |
For treatment of infections of the urinary tract, meninges, and blood stream, caused by susceptible strains of Pseudomonas aeruginosa. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A07AA05; J01XB02; S01AA18; S02AA11; S03AA03 |
| DrugBank ID |
DB00781
|
| KEGG ID |
D08401
|
| MeSH ID |
D011112
|
| PubChem ID |
49800004
|
| TTD Drug ID |
D09OOV
|
| NDC Product Code |
55150-234; 39822-0166 |
| Synonyms |
Polymyxin B | Polymyxin B Sulfate | Aerosporin |
|
| Chemical Information |
| Molecular Formula |
C56H98N16O13 |
| CAS Registry Number |
1404-26-8 |
| SMILES |
CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)
C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
